Navigation Links
Risk-Management Policies Needed Now in Nanotechnology, Insighter Piece Concludes; FDLI Sponsors Nanotechnology Meeting, Publishes Book on FDA-Regulated Products
Date:2/3/2009

WASHINGTON, Feb. 3 /PRNewswire-USNewswire/ -- Companies that manufacture products containing nanomaterials must immediately institute high-quality risk management and product stewardship measures to limit potential liability exposure in the future, assert attorneys Jesse Ash, Antony Klapper and James Wood.

This issue will be thoroughly explored at FDLI's 2nd Annual Conference on Nanotechnology Law, Regulation and Policy, February 18-19, 2009, in Washington, D.C., and discussed in a book to be published by FDLI February 17, Nanotechnology & FDA-Regulated Products: The Essential Guide. At the conference, six top officials of the Food and Drug Administration will answer questions about how the new Administration intends to regulate nanotechnology products.

In their Insighter article on the Food and Drug Law Institute's website (www.fdli.org), Ash, Klapper and Wood, part of a team of more than two dozen attorneys involved in nanotechnology issues at the law firm of Reed Smith, note that while there has not been a single lawsuit filed where someone claimed injury because they were exposed to engineered nanomaterials, many scientists are raising questions regarding the manufacturing of nanomaterials and its effects on workforces, researchers and consumers. "For example," they write in the Insighter piece, "some scientists wonder whether engineered nanomaterials will become the next asbestos."

The attorneys point out that a recent study indicated that certain types of carbon nanotubes, graphite-based structures commonly used in nanotechnology applications, both resemble and behave like asbestos fibers. Because they are as light as plastic and stronger than steel, carbon nanotubes will likely see use in a variety of new applications, including medical nanodevices. Based on toxicity studies, scientists found that inhaling long, thin multi-walled carbon nanotubes had the potential to cause lung disorders similar to those caused by exposure to asbestos. Because there are many unanswered questions regarding risk, it is essential that companies follow the principles of good product stewardship activities and good risk management strategies in the design and manufacturing of products made with engineered nanomaterials, the authors conclude.

To register for the conference, order the book or view the entire Insighter article, visit www.fdli.org


'/>"/>
SOURCE Food and Drug Law Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Following Ceremony with President Obama, UAN President Ann Converso, RN, Commends New Administration on Meeting with Labor Leaders and Reinstating Pro-Worker Policies
2. Facing Large and Uncontrollable Financial Losses on Individual Policies, Blue Cross Blue Shield of Michigan Will Cut Up to 1000 Jobs in 2009, Reduce Spending and Seek Rate Increases on Individual Plans
3. Pets Best Announces New Underwriter for Pet Insurance Policies
4. Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies
5. State policies have little effect on reducing minors indoor tanning use
6. Medicaid policies vary widely for rheumatoid arthritis drugs
7. The Lewin Group Presents McCain and Obama Health Policies: Cost and Coverage Compared Analysis
8. Tennessee Introduces Long-Term Care Partnership Insurance Policies and Producer Training Requirement
9. John McCains Health Care Plan Based on Same Policies That Are Causing Wall Street Meltdown
10. VOICES Launches Vote Kids 2008 to Engage Voters and Candidates in Shaping National Policies for Americas Children
11. New report warns current policies will not avert health workforce crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ongoing effort ... has recently developed and published an informational resource that addresses frequently asked questions. ... common inquiries the site’s team of third party administrator (TPA) contributors regularly receives ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon ... is thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. ... SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is ...
(Date:3/28/2017)... ... 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ages, ... to offer to the discussion of dealing with excess skin oil. “Oily skin is a ... remedies that can help remove the oily shine while keeping the skin fresh and clean,” ...
(Date:3/27/2017)... Aurora, CO (PRWEB) , ... March 27, 2017 , ... ... Dr. Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep ... the condition, which can include daytime sleepiness, morning headaches and chronic snoring. , ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Akcea Therapeutics, a subsidiary ... to the company,s board of directors: ... Partners. Mr. Gabrieli will serve as chairman of the board ... former chief commercial officer of Forest Laboratories. ... Biolink Partners. "We are excited to ...
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
Breaking Medicine Technology: